Chemotherapy-Induced Neuropathic Pain: Victories and Defeats
Chemotherapy-induced peripheral neuropathy (CIPN) is among the most lingering and difficult of chemotherapy-associated adverse events. Etiologies are various, and the evidence base for treatment is sparse. This program explores the mechanisms and epidemiology of CIPN, surveys the literature for current treatments, and looks ahead to next steps in the development of treatments.
Faculty: W. Clay Jackson, MD, DipTh
This .5-hour CE activity is designed for all clinicians who treat chronic pain.
Upon completion of this activity, participants should be better able to:
- Name three chemotherapeutic agents or classes associated with CIPN
- Name the one current therapeutic agent that demonstrated efficacy for CIPN in an NCCI-sponsored randomized controlled trial
- Discuss the potential role of peripheral sensitization in CIPN and how new treatments may target this pathway
Policy on Privacy and Confidentiality
AIPM does not share your personal information provided to this site with any third party, except where required by CE governing bodies for verification of CE activities. Your email address will only be used to contact you in relation to your activities on the website.
The information provided in this activity is for continuing education purposes only and is not meant to subsitute for the independent medical judgement of a health care provider relative to diagnostic and treatment options of a specific patient's medical condition.
Presentations used with permission. Copyright © Academy of Integrative Pain Management 2018
For questions regarding CME for this activity, you may reach the department of education at the Academy of Integrative Pain Management at firstname.lastname@example.org.
W. Clay Jackson, MD, DipTh, vice-president of the AIPM Board, is clinical assistant professor of family medicine and psychiatry at the University of Tennessee College of Medicine in Memphis, where he maintains a private practice in family and palliative medicine. He is also the medical director of Comprehensive Primary Care and of Methodist Hospice and Palliative Services. Dr. Jackson is the associate fellowship director of palliative medicine at the University of Tennessee College of Medicine. He is board certified in family practice and hospice and palliative medicine, and is a frequent presenter at national conferences on the treatment of chronic pain. His work has been published in a number of leading academic journals and he is a recipient of numerous teaching honors.
Disclosure of Conflict of Interest
All individuals in a position to control the content who had relevant financial relationships are listed below. If their name is not listed below, they disclosed that they had no relevant financial relatioships.
Dr. Jackson reports that he has investments in Aspire Healthcare.
Acknowledgement of Commercial Support
No commercial support was received for this educational activity.
Method of Learner Participation: Each learner will listen to each audio self-directed module while following along with the visual slides. Upon completion, each learner will answer evaluation questions to receive their certificate.
Satisfactory Completion: Learners must complete an evaluation to receive a certificate of completion. Your chosen sessions/videos must be viewed in their entirety.
Bibliographic Sources: Bibliographic sources can be found on the program slides.
The Academy of Integrative Pain Management is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Academy of Integrative Pain Management designates this live activity for a maximum of .5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
The American Osteopathic Association accepts ACCME accredited programs for Category 2-A CME credit.
Nurses and Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco, LLC and the Academy of Integrative Pain Management. Amedco, LLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco designates this enduring material activity for a maximum of .5 contact hour for nurses and .5 knowldege-based contact hour for pharmacists. Learners should claim only the credit commensurate with the extrent of their participation in the activity. PHARMACIST NOTE: The only offiical Statement of Credit is the one you pull from CPE Monitor.
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit.
- 0.50 ACPE
- 0.50 AMA PRA Category 1 Credit(s)™
- 0.50 ANCC
- 0.50 Document of Attendance